ESS vs TELO · P/E 31, rev $1.89B vs $86.0M cap
Essex Property Trust Inc (ESS) versus Telomir Pharmaceuticals, Inc. Common Stock (TELO) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a biotechnology company listed on NASDAQ.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
TELO does not have a complete income-statement cache yet.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. TELO currently screens at market cap $86.0M.
Not investment advice. Open the ESS and TELO stock pages for the full models.
Not investment advice.